Literature DB >> 18208894

Receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin levels in multiple sclerosis.

Sevil Kurban, Zehra Akpinar, Idris Mehmetoglu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18208894     DOI： 10.1177/1352458507084028

Source DB:  PubMed          Journal:  Mult Scler        ISSN： 1352-4585            Impact factor:   6.312


× No keyword cloud information.
  10 in total

Review 1.  Cardiovascular Autonomic Dysfunction: Link Between Multiple Sclerosis Osteoporosis and Neurodegeneration.

Authors:  Zohara Sternberg
Journal:  Neuromolecular Med       Date:  2018-02-10       Impact factor: 3.843

2.  Bone health in patients with multiple sclerosis.

Authors:  Vit Zikan
Journal:  J Osteoporos       Date:  2011-03-30

3.  Body composition in multiple sclerosis.

Authors:  Y Dionyssiotis
Journal:  Hippokratia       Date:  2013-01       Impact factor: 0.471

4.  Correlation of circulating omentin-1 with bone mineral density in multiple sclerosis: the crosstalk between bone and adipose tissue.

Authors:  Majid Assadi; Hooman Salimipour; Samad Akbarzadeh; Reza Nemati; Syed Mojtaba Jafari; Afshar Bargahi; Zahra Samani; Mohammad Seyedabadi; Zahra Sanjdideh; Iraj Nabipour
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

5.  Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features.

Authors:  Yannis Dionyssiotis
Journal:  Int J Gen Med       Date:  2011-07-04

6.  Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study.

Authors:  Mehdi Moghaddasi; Mahbubeh Aghaei
Journal:  Iran J Neurol       Date:  2013

7.  Characterisation of Transcriptional Changes in the Spinal Cord of the Progressive Experimental Autoimmune Encephalomyelitis Biozzi ABH Mouse Model by RNA Sequencing.

Authors:  Ioanna Sevastou; Gareth Pryce; David Baker; David L Selwood
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

8.  Propofol attenuates osteoclastogenesis by lowering RANKL/OPG ratio in mouse osteoblasts.

Authors:  Do-Won Lee; Jae-Young Kwon; Hae-Kyu Kim; Hyeon-Jeong Lee; Eun-Soo Kim; Hyae-Jin Kim; Hyung-Joon Kim; Han-Bit Lee
Journal:  Int J Med Sci       Date:  2018-05-14       Impact factor: 3.738

9.  RANK/RANKL/OPG Signaling in the Brain: A Systematic Review of the Literature.

Authors:  Anton Glasnović; Niall O'Mara; Nataša Kovačić; Danka Grčević; Srećko Gajović
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

10.  Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity.

Authors:  Trygve Holmøy; Kristin Ingeleiv Løken-Amsrud; Søren Jacob Bakke; Antonie G Beiske; Kristian S Bjerve; Harald Hovdal; Finn Lilleås; Rune Midgard; Tom Pedersen; Jutrate Saltytė Benth; Oivind Torkildsen; Stig Wergeland; Kjell-Morten Myhr; Annika E Michelsen; Pål Aukrust; Thor Ueland
Journal:  PLoS One       Date:  2013-09-19       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.